Stem-cell purity & characterisation: how a cell product's identity, phenotype and quality are verified

1. What "stem-cell purity" actually means

Ask what makes a chemical pure and the answer is simple: one molecule, no others. Cells are harder. A stem-cell preparation is a living population, and "purity" folds together several distinct questions — identity (are these the cells we think they are?), homogeneity (is the population one thing, or a mix?), genomic integrity (has the genome drifted in culture?), sterility (is it free of bacteria, fungi, mycoplasma and endotoxin?) and potency (do the cells still do what they are meant to do?). A preparation can be sterile yet mis-identified, or correctly identified yet carrying an abnormal karyotype. Each question needs its own measurement.

Stem cells¹ add a further wrinkle. Their defining properties — self-renewal and the ability to become other cell types — are the same properties that make them drift: long culture selects for faster-growing variants, and differentiation can begin quietly at the colony edges. Purity for a stem cell therefore includes how pluripotent or how committed the cells are, not just what species and line they belong to.

2. The characterisation toolkit

Characterisation is how identity and quality are turned from an assumption into a measured record. A modern cell-product panel combines several orthogonal methods, each answering a different question:

The phenotyping markers are worth a closer look, because they are what most people mean by "purity" in practice. In flow cytometry, cells flow single-file past a laser; fluorescent antibodies bound to surface proteins light up, and the instrument counts how many cells carry each marker. A pluripotent line is expected to be strongly positive for markers such as SSEA-4 and TRA-1-60 and negative for early differentiation markers; a mesenchymal stromal population is defined by a positive CD73/CD90/CD105 signature and the absence of haematopoietic markers. The percentage of cells matching the expected pattern is the purity figure that a release record reports.

3. Why it matters — the open frontier

For research, a mis-characterised culture wastes time. For a cell product — cells grown to be administered to a person — identity, homogeneity and function are the product. The ambition of the field is consistent, well-characterised cell products made at scale: banks of pluripotent or engineered cells with a stable phenotype, expanded under controlled conditions, each batch matching the last. That is a manufacturing problem as much as a biological one, which is why cell products are increasingly made under GMP-style controls, with characterisation built into every step rather than bolted on at the end.

One step sits stubbornly across the whole ambition: getting the cells there. Cells are banked and shipped frozen, and freezing is where a great deal of carefully verified quality can quietly be lost. Ice does not form politely — left to itself it nucleates at random, and jagged intracellular crystals rupture membranes. Cryoprotectants such as DMSO blunt the damage but add their own stress, and the same violence returns on thaw. A batch that passed every purity check while alive can arrive with lower viability and a shifted phenotype. How cells are frozen, stored and thawed is therefore part of the product's identity, not an afterthought — and controlling the moment of ice formation is one of the most active frontiers in biopreservation.

4. Where Panacea Bio Chem works

Panacea Bio Chem researches the preservation and controlled handling of fragile biological material — the last, unglamorous mile in which a well-characterised sample has to survive freezing, storage and reconstitution with its identity intact. The group's direction points at the moment of freezing itself: rather than letting ice nucleate at random, its work explores controlled, deterministic nucleation and gentle, sensor-led handling, so the physical process that most threatens a cell's measured phenotype is directed rather than left to chance. The same preservation thinking runs through its drying and stabilisation technologies — Cryolapse™, gentle low-temperature sublimation, TgShift™, which lifts the glass-transition ceiling of the protective matrix, LyoLevit™, containerless drying, and RedoxVault™, isolation from oxygen and metals — each orchestrated by the S3Pulse™ biointegrity algorithm.

The exact thermal choreography, nucleation timing, sequences and hardware that make this controlled preservation repeatable remain proprietary to Panacea Bio Chem and are held by Bogdan Dicoias. The outline is here; the recipe stays behind the door.

5. Application fields

Where does purity-first, preservation-aware cell science hit hardest? A few directions stand out — equally as fields of use and as inspiration for future research and trials:

• Off-the-shelf allogeneic cell banks — master and working cell banks of induced-pluripotent or engineered lines, where every vial must thaw to the same characterised phenotype for the model to work.
• Engineered immune-cell products — identity, homogeneity and viable recovery after freezing are release-defining for cell therapies; the frozen-to-bedside journey is where quality is won or lost.
• Regenerative and organoid research — multipotent stromal cells and 3-D tissue models whose downstream behaviour depends on a stable, verified starting population.
• Biobanking & distributed sourcing — non-invasively sourced cells such as urine-derived stem cells and rare populations like Muse cells, where the value of a hard-won sample rides entirely on preserving it intact.
• Potency-linked release testing — tying a functional assay to the characterisation record, so "purity" means capable of its intended action, not merely correctly labelled.

Authenticating your own cell line — the practical path

The identity trap is not only history. Misidentified and cross-contaminated lines remain in circulation, and the International Cell Line Authentication Committee (ICLAC) maintains a public register of them⁹. For a researcher holding a vial, authentication is a concrete routine rather than a principle:

1. Profile the line. Commission short-tandem-repeat (STR) profiling from a service laboratory — the standardised fingerprint from the toolkit table above, formalised as the field's authentication method by Barallon and colleagues³.
2. Compare against a reference. Match the profile against the reference STR databases that the major public cell repositories (such as ATCC and ECACC) publish for their lines.
3. Check the register. Look the line up in the ICLAC register of misidentified and cross-contaminated lines before building experiments on it⁹.
4. Keep the evidence with the batch. File the STR report alongside the batch record; journals and funders increasingly ask for an authentication statement.

Two honest limits. STR profiling answers which line this is — it says nothing about phenotype, potency, or drift within an authentic line, which is why it sits beside flow cytometry and karyotype rather than replacing them. And a percentage-purity readout is only as meaningful as the gating strategy behind it: the same sample can yield different figures under different gates, so a purity number belongs on the record together with the method that produced it. ICLAC register link last checked 2026-09-10.

Anatomy of a characterisation record

What does the end product of all this measurement look like? A characterisation record — the document that accompanies a banked or released cell preparation — answers the five purity questions line by line. The example below is fictional and illustrative: it shows the shape of a record, not data from any real product.

Read this way, "purity" on a record is never one number. Flow-cytometric assays organised around exactly these identity, sterility and potency questions are mapped for cell therapies by Campbell⁸, and the mesenchymal marker signature traces to the ISCT position statement of Dominici and colleagues⁷. Every percentage on such a record is method-dependent — meaningful only with its assay and its gates stated beside it.

Frequently asked

Trending in the field

References & further reading

1. Stem cell. Wikipedia.
2. Flow cytometry. Wikipedia.
3. Barallon et al., Recommendation of short tandem repeat profiling for authenticating human cell lines. PubMed (2010).
4. HeLa — cell-line cross-contamination & authentication history. Wikipedia.
5. Induced pluripotent stem cell. Wikipedia.
6. Cryopreservation. Wikipedia.
7. Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells — the International Society for Cellular Therapy position statement. Cytotherapy, 2006. PubMed.
8. Campbell, Flow cytometric assays for identity, safety and potency of cellular therapies. Cytometry Part B, 2018. doi.
9. International Cell Line Authentication Committee (ICLAC) — register of cross-contaminated or misidentified cell lines. iclac.org.